CompaniesIntersect ENT

Intersect ENT

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (14)
View all

Total Trials

14

As Lead Sponsor

12

As Collaborator

2

Total Enrollment

1,100

By Phase

NA: 6PHASE3: 4PHASE4: 1PHASE2: 1PHASE2/PHASE3: 1

By Status

COMPLETED: 14
Clinical Trials Pipeline14 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Today
Hover over trial bars to see details

Recent Trials

NCT04858802Lead Sponsor
A Clinical Evaluation of PROPEL® Contour Sinus Implant
NACompleted
80 participants
Started: May 12, 2021 · Completed: Jun 20, 2022
NCT03599271Lead Sponsor
A Clinical Evaluation of the Intersect ENT Sinus Device (ASCEND)
N/ACompleted
75 participants
Started: Jun 12, 2018 · Completed: Dec 9, 2020
NCT03358329Lead Sponsor
Safety Evaluation of Repeat Placement of the S8 Sinus Implant in Chronic Sinusitis Patients With Nasal Polyps (ENCORE)
PHASE3Completed
50 participants
Started: Nov 13, 2017 · Completed: Jan 17, 2019
NCT02880514Lead Sponsor
In-office Placement of the Propel Mini Sinus Implant in the Frontal Sinus Ostia
NACompleted
50 participants
Started: Aug 31, 2016 · Completed: Jun 30, 2017
NCT02687438Collaborator
The PIO (Propel In Office) III Study of In-office Placement of a Steroid-Eluting Implant Immediately Following Ethmoid Sinus Surgery
NACompleted
20 participants
Started: Dec 31, 2015 · Completed: Feb 29, 2016
View all 14 trials →
Funding History (20)
8-K
May 13, 2022
Filing
8-K
May 9, 2022
Filing
8-K
Apr 18, 2022
Filing
8-K
Mar 23, 2022
Filing
8-K
Nov 2, 2021
Filing
8-K
Oct 8, 2021
Filing
DEFA14A
Sep 30, 2021
Filing
DEFA14A
Sep 27, 2021
Filing
8-K
Sep 27, 2021
Filing
8-K
Sep 27, 2021
Filing
Related Companies
Medtronic
acquired